Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a ...

Chikungunya is transmitted to humans through the bite of infected female mosquitoes, particularly Aedes aegypti and Aedes ...

Robert F. Kennedy Jr. testified on May 14 before the House Appropriations and the Senate Health, Education, Labor and ...

The latest numbers from the Centers for Disease Control and Prevention show the measles outbreak has surpassed 1,000 cases ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

A vaccine designed to protect against chikungunya, a mosquito-borne illness, has been temporarily paused for individuals aged 60 and older.

The Centers for Disease Control and Prevention and the Food and Drug Administration posted notices late last week, advising ...

The US Centers for Disease Control and Prevention are back in Texas and on the ground for the second time this year. The state has become ground zero for one of the worst measles outbreaks the country ...

A second chikungunya vaccine may soon be available for travelers, officials say TUESDAY, May 13, 2025 (HealthDay News) — U.S.

The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.